Diagnosed with High-Risk Myeloma: What Now?
High-risk multiple myeloma is still a serious diagnosis, but not one without hope. Learn how to define high-risk myeloma, outcomes versus standard-risk, treatment differences, and the hope for the future of high-risk myeloma. We look forward to learning with you and getting your questions answered.
Marisol introduces the agenda of the event and featured speaker Danai Dima.
Danai Dima talks about high-risk myeloma versus standard-risk.
Type your questions in the chat and we will answer them!
Marisol Garcia
Marisol es la manager de operaciones de eventos en la fundación de HealthTree. En conjunto con los Managers de educación trabajan para traer reuniones de diferentes temas de interés para los pacientes. Estudió ingeniería industrial y aprovecha sus conocimientos para hacer lo que le apasiona, coordinar eventos mientras enseña y ayuda a pacientes y sus familias. Su misión es hacer llegar nuestro programa a más gente, tanto en inglés como en español.
Danai Dima
Danai Dima is a third-year hematology-oncology fellow at Clinical Clinic, with clinical interest in plasma cell dyscrasias including multiple myeloma, and light chain amyloidosis, and CAR T cell therapies. She completed her medical education at the University of Athens in Greece and her internal medicine residency at Tufts Medical Center in Boston.